I think you have totally failed to grasp the point about patents. Many drugs, take aspirin as a common example, have started out as plant extracts. A patent is effectively gives a drug company a monopoly over a formulation for a given product for a set period of time. Patents and product approval = £££££. GW Pharma are one of the few companies who are going down the route of developing pharmaceutical products derived from cannabis. That requires a lot of money for trials and research. As I have said before, a medical practitioner cannot prescribe an unlicensed medicine. Do not confuse the recreational side of cannabis with the medical side. You may think that that the patents are complete rubbish, but they are the foundation of a drug industry worth hundreds of billions of pounds.
Dr Shaggy, I can't comment on the patents as I'm no scientist or patent expert. I agree that if cannabis becomes legal then self medication will be an option for some people. Lets face it is already is. Despite criminalisation a massive number of people worldwide 'self medicate' with cannabis on a daily and weekly basis already! Some people will just grow their own of course!
But some patients will find eating or smoking very difficult so the inhaler idea from GW is a good one. The other thing is that unless cannabis becomes heavily regulated no one self medicating can be guaranteed that each batch / sample they are using will be the same as before. So I think its highly unlikely Doctors will ever prescribe cannabis as a raw material, unless growers adopt pharmaceutical style quality procedures and testing.
Cannabis growers don't like GW for a lot of reasons. They are very much seen as 'Big Pharma' although GW are a very small pharma company in reality. The one thing GW are doing is proper clinical trials that costs millions and millions of pounds. This is good as hopefully the results will show that cannabis work as a pharmaceutical drug but consistency of product is going to absolutely key and small-scale hobby cannabis growers will have to scale up and become much more professional than they are at the moment. From what I can see at the moment US cannabis growers are using growing models based on high recreational sales prices - this won't be sustainable and nor will their growing model going forward as the raw material prices of pharmaceutical cannabis is probably in the long term going to be cheaper that recreational prices.
I don't think GW have a lot to worry about continued cannabis legislation going forward. I think what they are doing is quite different to what traditional cannabis growers are doing. Patents just help in the short term in raising cash and if GW ever sell the business. The big test for GW will be the results of all the clinical trials. If GW can get cannabis into hospitals and dispensed by Dr's etc then they have a product and a value. Without this they have no business value.
I have to agree with quite a few of your points, pretty much what i was saying months and months ago, but.....BUT.... I think that quite a few people, namely ones that dont already use cannabis would be happier with a pharma product. look at this example, and look at what she is saying - im not saying she is right, and i think there is huge confusion in america regarding GWP and cannabis (marijuana) legalisation over there. many people seem to think that they need a law change for epilodex to be legal, when in fact all GWP need is FDA approval.
Also look at Canada and how bedrocan are pushing the notion of mould, frankly i think its nonsense, and personally i would prefer non irradiated cannabis bud , but those in power are easily led by these sort of fears, and i think that parents of children with epilepsy etc would prefer a tested , standardised product. (as long as its effective) the patents will protect GWP by stopping anyone else making claims and selling cannabis products specifically to treat certain conditions, the stanley brothers cant legally make claims about CW, they can only suggest it may help and once GWP get FDA approval i think the next step will be a clampdown on the claims made by the realm of caring. i could be wrong. (a lot depends on whether epilodex is proven to be more effective)
AS GWP have made epilodex 99% pure we have no way of knowing if a full plant extract could have better efficacy, they should of trailed two products IMO - pure, and full plant extract containing all the other compounds, just to test the entourage effect.
I do agree that gwp have not invented anything, but that didn't stop edison, history does repeat itself. My feeling is that gwp only look at producing solutions to political problems, they provide the 'easy' answer to politicians that have no where else to turn when public pressure dictates change. - the fact sativex was priced in line with the street price of illicit cannabis kind of gives the game away a bit, also GWP had to ask the question - "do we even have a product" * when the USA was besieged by crying moms pushing for CBD oil, quite strange how they managed to get it to 'market' so quickly.
When questioned, every person that i have asked that do not use cannabis have stated to me that they would prefer a pharma product if needed than home grown, and i dont think that opinion will change any time soon, especially when companies like bedrocan push the notion of mould and contaminants, whereas anyone that already uses cannabis would prefer home grown, or professionally grown real bud. like i said though, i do actually agree with most of your post ;) however, i still think the SP will go up and gwp will do well. *quote by the CEO JG.
All of those cannabinoid profiles in 20140377382 can be found in varying quantities in most raw unprocessed (ie: undried) cannabis. The profiles found in 20140378539 are simply a mix of raw cannabis extract and decarboxylated cannabis extract.
How GWP can claim a patent on something they've supposedly 'invented' is utterly laughable given that one is simply extracted from raw non-decarboxylated cannabis (ie: not heat-treated), whereas the other is a mix of decarboxylated and non-decarboxylated extracts, along with the natural terpenes, flavenoids, chlroophyll that occur naturally in the plant. Some 'invention', lol!
They don't even specify the % of each component, which can be found in varying proportions in any raw/processed cannabis. Seems to me that they're actually trying to patent cannabis oil itself, in both its non-decarboxylated and carboxylated form.
Ironically, the US government patented CBD back in 2003 for its neuro-protective qualities. It's not a patent that the US government has been able to enforce, so there's no reason to think that GWP will be able to enforce it either.
It's been known among the medical marijuana fraternity for years that these conditions are treatable using medical marijuana. The idea that GWP's invented anything which hasn't already being discovered is sophistry.
The first patent is the equivalent of eating raw wet cannabis. The second is eating raw cannabis and ingesting any standard cannabis oil extract.
People already do this in the US without patents, trials, etc. The laws in the 25+ US states where medical marijuana is legalised don't require patented, standardised cannabis products like GWP are trying to offer. This, and the ongoing legalisation of cannabis throughout the US and other countries will blow GWP out of the water over the next few years.
GWP will never make money because people will self-medicate. Medical marijuana enthusiasts are suspicious of pharmaceutical companies, and this will work against GWP long-term. Cannabis as a medicine is unique in that it doesn't need pharmaceuticalization for patients to accept it. It's a medicine that exists outside the current medicinal/pharmaceutical paradigm, ie: as a traditional herbal remedy. It's a herbal remedy that actually works much more effectively than most pharmaceutical products developed for the same illnesses. It's safety has been tested for thousands of years, so all the trials do is confirm what people already know. It's medicine by the people, for the people, and pharmaceutical companies need to stay away.
All IMO of course. Needless to say, I won't be investing in them again. But good luck to all investors who want to stick with them.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.